Total Payments
$825,853
2024 Payments
$60,979
Companies
57
Transactions
1,701
Medicare Patients
15,732
Medicare Billing
$2.1M
Payment Breakdown by Category
Other$343,432 (41.6%)
Consulting$176,913 (21.4%)
Royalty/License$154,538 (18.7%)
Travel$94,637 (11.5%)
Food & Beverage$56,122 (6.8%)
Gifts$185.15 (0.0%)
Education$26.91 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $176,913 | 86 | 21.4% |
| Royalty or License | $154,538 | 1 | 18.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $124,655 | 44 | 15.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $105,500 | 27 | 12.8% |
| Travel and Lodging | $94,637 | 277 | 11.5% |
| Honoraria | $71,725 | 30 | 8.7% |
| Food and Beverage | $56,122 | 1,214 | 6.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $39,750 | 12 | 4.8% |
| Charitable Contribution | $1,725 | 1 | 0.2% |
| Gift | $185.15 | 3 | 0.0% |
| Entertainment | $76.77 | 2 | 0.0% |
| Education | $26.91 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Research Ltd | $154,538 | 1 | $0 (2018) |
| Shire North American Group Inc | $148,660 | 242 | $0 (2019) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $135,666 | 244 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $88,892 | 155 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $73,827 | 129 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $63,063 | 107 | $0 (2017) |
| Omeros Corporation | $50,632 | 61 | $0 (2021) |
| Kala Pharmaceuticals, Inc. | $46,015 | 89 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $8,549 | 41 | $0 (2022) |
| EYEVANCE PHARMACEUTICALS LLC | $8,202 | 34 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $60,979 | 209 | Bausch & Lomb Americas Inc. ($55,016) |
| 2023 | $26,202 | 145 | Bausch & Lomb Americas Inc. ($19,423) |
| 2022 | $22,234 | 146 | Bausch & Lomb Americas Inc. ($14,453) |
| 2021 | $39,125 | 192 | Bausch & Lomb, a division of Bausch Health US, LLC ($19,603) |
| 2020 | $33,019 | 113 | Omeros Corporation ($12,471) |
| 2019 | $190,333 | 326 | Bausch & Lomb, a division of Bausch Health US, LLC ($76,006) |
| 2018 | $270,046 | 224 | Alcon Research Ltd ($154,538) |
| 2017 | $183,916 | 346 | Shire North American Group Inc ($66,859) |
All Payment Transactions
1,701 individual payment records from CMS Open Payments — Page 1 of 69
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Consulting Fee | Cash or cash equivalent | $1,700.00 | General |
| Category: Ophthalmology | ||||||
| 12/26/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $9.08 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/16/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/11/2024 | Bausch & Lomb Americas Inc. | ENVISTA ENVY (Device) | Food and Beverage | In-kind items and services | $180.08 | General |
| Category: Ophthalmology | ||||||
| 12/11/2024 | NEW WORLD MEDICAL,INC. | Kahook Dual Blade (Device), Clearpath, Ahmed Glaucoma Valve | Food and Beverage | In-kind items and services | $159.25 | General |
| Category: Ophthalmology | ||||||
| 12/11/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: Musculoskeletal | ||||||
| 12/10/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $7.48 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/09/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: OPTOMETRY | ||||||
| 12/08/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Travel and Lodging | In-kind items and services | $557.45 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Travel and Lodging | In-kind items and services | $253.12 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $119.41 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $50.75 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Ophthalmology | ||||||
| 12/07/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Ophthalmology | ||||||
| 12/06/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Travel and Lodging | In-kind items and services | $253.12 | General |
| Category: Ophthalmology | ||||||
| 12/06/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $149.88 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 12/06/2024 | Bausch & Lomb Americas Inc. | STELLARIS ELITE (Device), enVista MX60 IOL, Trulign IOL | Travel and Lodging | In-kind items and services | $40.75 | General |
| Category: Ophthalmology | ||||||
| 12/06/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/05/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $117.10 | General |
| Category: SOLUTION/ DROPS | ||||||
| 12/05/2024 | Harrow Eye, LLC | IHEEZO (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: OPTOMETRY | ||||||
| 12/04/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $3,400.00 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | Harrow Eye, LLC | IHEEZO (Drug) | Food and Beverage | In-kind items and services | $36.59 | General |
| Category: OPTOMETRY | ||||||
| 12/04/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 4,134 | 5,668 | $1.2M | $576,167 |
| 2022 | 27 | 4,651 | 6,541 | $1.4M | $614,553 |
| 2021 | 26 | 4,126 | 5,639 | $1.4M | $555,851 |
| 2020 | 22 | 2,821 | 3,640 | $1.2M | $369,797 |
Total Patients
15,732
Total Services
21,488
Medicare Billing
$2.1M
Procedure Codes
102
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 193 | 297 | $349,827 | $133,782 | 38.2% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 319 | 805 | $165,405 | $77,795 | 47.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 618 | 1,049 | $129,016 | $74,823 | 58.0% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 175 | 185 | $98,609 | $60,352 | 61.2% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 406 | 472 | $83,734 | $46,272 | 55.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 299 | 380 | $64,165 | $38,917 | 60.7% |
| 65730 | Penetrating transplantation of tissue from 1 cornea to other cornea (except in aphakia or pseudophakia) | Facility | 2023 | 26 | 29 | $79,052 | $30,648 | 38.8% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 181 | 181 | $40,270 | $19,615 | 48.7% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 20 | 26 | $42,563 | $15,993 | 37.6% |
| 92025 | Ct scan of cornea | Office | 2023 | 412 | 472 | $24,019 | $14,326 | 59.6% |
| 92134 | Imaging of retina | Office | 2023 | 342 | 391 | $21,693 | $12,728 | 58.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 131 | 139 | $17,236 | $9,965 | 57.8% |
| 92250 | Photography of the retina | Office | 2023 | 274 | 299 | $15,944 | $8,467 | 53.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 96 | 140 | $11,221 | $6,484 | 57.8% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 72 | 80 | $7,492 | $4,294 | 57.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 44 | 44 | $6,756 | $3,631 | 53.7% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 60 | 77 | $6,178 | $3,385 | 54.8% |
| 68841 | Insertion of drug delivery implant into tear duct of eye | Facility | 2023 | 154 | 215 | $15,035 | $2,992 | 19.9% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 43 | 43 | $4,996 | $2,981 | 59.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $4,242 | $2,550 | 60.1% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 36 | 39 | $2,455 | $1,361 | 55.4% |
| 92133 | Imaging of optic nerve | Office | 2023 | 42 | 45 | $2,232 | $1,313 | 58.8% |
| 67820 | Removal of eyelashes using forceps | Office | 2023 | 49 | 74 | $1,972 | $1,106 | 56.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 12 | 12 | $1,694 | $993.94 | 58.7% |
| 92285 | Photography of content of eyes | Office | 2023 | 36 | 39 | $1,251 | $717.36 | 57.3% |
About Dr. Douglas Katsev, MD
Dr. Douglas Katsev, MD is a Ophthalmology healthcare provider based in Santa Barbara, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801906722.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Katsev, MD has received a total of $825,853 in payments from pharmaceutical and medical device companies, with $60,979 received in 2024. These payments were reported across 1,701 transactions from 57 companies. The most common payment nature is "Consulting Fee" ($176,913).
As a Medicare-enrolled provider, Katsev has provided services to 15,732 Medicare beneficiaries, totaling 21,488 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Santa Barbara, CA
- Active Since 08/30/2006
- Last Updated 02/14/2023
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1801906722
Products in Payments
- NGENUITY (Device) $154,538
- XIIDRA (Drug) $131,211
- MIEBO (Drug) $44,785
- INVELTYS (Drug) $41,315
- OMIDRIA (Drug) $37,110
- OPHTHALMIC INSTRUMENTS (Device) $31,803
- STELLARIS ELITE (Device) $31,408
- STELLARIS PC (Device) $29,057
- Bromsite (Drug) $26,488
- LOTEMAX SM (Drug) $24,405
- LOTEMAX GEL (Drug) $19,954
- PROLENSA (Drug) $19,461
- BromSite (bromfenac ophthalmic solution) 0.075% (Drug) $16,662
- Omidria (Drug) $13,562
- CEQUA (Drug) $13,266
- BROMSITE (Drug) $12,719
- STELLARIS (Device) $9,630
- AKREOS AO (Device) $8,885
- Flarex (Drug) $6,160
- EYSUVIS (Drug) $4,859
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Santa Barbara
Dr. Nathan Steinle, M.d, M.D
Ophthalmology — Payments: $1.2M
Ophthalmology $1.2M
Daniel Learned, M.d, M.D
Ophthalmology — Payments: $43,350
Ophthalmology $43,350
Michael Paveloff, Md, MD
Ophthalmology — Payments: $40,714
Ophthalmology $40,714
Dr. Stephen Couvillion, Md, MD
Ophthalmology — Payments: $27,316
Ophthalmology $27,316
Dr. Stuart Winthrop, M.d, M.D
Ophthalmology — Payments: $5,752
Ophthalmology $5,752
Dr. Robert Poulin, M.d, M.D
Ophthalmology — Payments: $4,450
Ophthalmology $4,450